|
Market Closed -
CBOE
11:00:00 2026-10-08 am EDT
|
5-day change | 1st Jan Change | ||
| 6,645.59 HUF | 0.00% |
|
0.00% | +1.07% |
| Sep. 18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| Aug. 11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,060B | |||||
| 623B | - | ||||
| 480B | |||||
| 352B | |||||
| 345B |
Select your edition
All financial news and data tailored to specific country editions
